Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Evaluation of antiretroviral therapy combining Raltegravir and Maraviroc in patients with
virological success, presenting with clinical lipohypertrophy.
Phase:
Phase 2
Details
Lead Sponsor:
ANRS, Emerging Infectious Diseases French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)